Trial Profile
AN OPEN, PILOT PHASE III, RANDOMIZED CLINICAL TRIAL TO ASSESS THE TISSUTAL PHARMAKINETICS OF MESALAZINE TABLETS IN PATIENTS WITH MILD TO MODERATE LEFT-SIDED ULCERATIVE COLITIS IN ACTIVE PHASE.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 01 Nov 2012
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Nogra Pharma
- 04 Aug 2011 New trial record